ARCA:XBI

SPDR Biotech ETF

$ 97.1 0.77 ( +0.8%) 04:00 PM EST
PE Ratio:
18.01
PB Ratio:
4.1
Volume:
5.41M
Dividend Yield %:
0.2
Last Holding update 2024-08-28 139 Stocks (12 new)
Value $7.12 Bil Turnover 32 %
Top Holdings: SRPT(3.31%) UTHR(2.98%) ALNY(2.86%) GILD(2.84%) AMGN(2.82%)
Portfolio Report
Registrant: SPDR SERIES TRUST
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Key Statistics

Name Value
Day's Open ($) 96.7
Day's Range ($) 96.1 - 97.76
Day's Volume 5,409,247
52-Week Range ($) 63.8 - 103.52
Beta 0.92
Volatility 31.47
14-Day RSI 39.88
14-Day ATR ($) 1.93549
20-Day SMA ($) 99.098

Fundamental Data

Name Value
Market Cap (Mil $) 7,573.8
Shares Outstanding (Mil) 78
PE Ratio 18.01
PE Ratio (10y Range) 14.4 - 22.67
PE Ratio (10y Median) 22.67
PB Ratio 4.1
PB Ratio (10y Range) 2.75 - 6.16
PB Ratio (10y Median) 4.65

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.192
Dividend Yield % 0.2
Dividend Yield % (10y Range) 0.01 - 0.81
Dividend Yield % (10y Median) 0.23
Next Dividend Payment Date
Dividend Frequency Quarterly

XBI SPDR Biotech ETF Fundamental Charts

Historical TTM Price-to-Earnings for XBI SPDR Biotech ETF

Historical TTM Price-to-Earnings without NRI for XBI SPDR Biotech ETF

Historical Price-to-Book Ratio for XBI SPDR Biotech ETF

Historical Dividend Yields for XBI SPDR Biotech ETF

XBI SPDR Biotech ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:XBI

No Available Data

ARCA:XBI is held by these investors

No Available Data
SPDR(R) S&P(R) Biotech ETF Top Holdings of 2024-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
SRPT 		Sarepta Therapeutics Inc
1,492,740
235852.920
+142.99%
3.310
+1.95%
1.570
-20.96%
+24.15%
11417.255
Biotechnology
UTHR 		United Therapeutics Corp
665,786
212086.130
+111.80%
2.980
+1.57%
1.500
+12.28%
+61.80%
15829.515
Biotechnology
ALNY 		Alnylam Pharmaceuticals Inc
839,404
203975.170
+64.59%
2.860
+1.12%
0.650
+6.30%
+41.68%
34815.511
Biotechnology
GILD 		Gilead Sciences Inc
2,948,105
202269.480
+189.87%
2.840
+1.86%
0.240
+27.32%
+8.57%
106035.537
Drug Manufacturers
AMGN 		Amgen Inc
642,185
200650.700
+130.06%
2.820
+1.59%
0.120
+2.71%
+12.73%
170698.747
Drug Manufacturers
ABBV 		AbbVie Inc
1,137,755
195147.740
+166.33%
2.740
+1.71%
0.060
+16.97%
+28.08%
340922.009
Drug Manufacturers
REGN 		Regeneron Pharmaceuticals Inc
184,998
194438.450
+134.50%
2.730
+1.57%
0.170
-4.47%
+14.46%
110814.360
Biotechnology
EXAS 		Exact Sciences Corp
4,579,772
193495.370
+259.90%
2.720
+1.96%
2.480
+51.74%
-7.31%
12669.672
Medical Diagnostics & Research
BIIB 		Biogen Inc
827,919
191928.180
+141.90%
2.700
+1.58%
0.570
-20.07%
-29.55%
26554.115
Drug Manufacturers
BMRN 		Biomarin Pharmaceutical Inc
2,296,837
189098.590
+158.37%
2.660
+1.63%
1.210
-16.92%
-28.76%
13077.394
Biotechnology

SPDR(R) S&P(R) Biotech ETF's Historical Top Holdings Breakdowns

SPDR(R) S&P(R) Biotech ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
EXAS 		Exact Sciences Corp2024-06-30Add
+1.96%
●
41.33 ($55.02) 74.26
$68.57
24.63%
Add 259.9%
4,579,772
3,307,248
SRPT 		Sarepta Therapeutics Inc2024-06-30Add
+1.95%
●
113.33 ($128.46) 163.85
$119.72
-6.80%
Add 142.99%
1,492,740
878,413
GILD 		Gilead Sciences Inc2024-06-30Add
+1.86%
●
63.15 ($66.73) 72.88
$85.21
27.69%
Add 189.87%
2,948,105
1,931,049
VKTX 		Viking Therapeutics Inc2024-06-30Add
+1.79%
●
47.39 ($65.55) 80.2
$66.68
1.72%
Add 226.24%
3,472,410
2,408,029
ABBV 		AbbVie Inc2024-06-30Add
+1.71%
●
154.79 ($165.65) 180.76
$193.01
16.52%
Add 166.33%
1,137,755
710,554
BMRN 		Biomarin Pharmaceutical Inc2024-06-30Add
+1.63%
●
74.43 ($83.25) 92.22
$68.69
-17.49%
Add 158.37%
2,296,837
1,407,882
AMGN 		Amgen Inc2024-06-30Add
+1.59%
●
262.75 ($293.78) 319.31
$317.68
8.14%
Add 130.06%
642,185
363,053
BIIB 		Biogen Inc2024-06-30Add
+1.58%
●
190.52 ($217.32) 236.72
$182.30
-16.11%
Add 141.9%
827,919
485,663
UTHR 		United Therapeutics Corp2024-06-30Add
+1.57%
●
228.26 ($264.67) 319.04
$355.79
34.43%
Add 111.8%
665,786
351,435
REGN 		Regeneron Pharmaceuticals Inc2024-06-30Add
+1.57%
●
883.2 ($969.4) 1071.19
$1,005.26
3.70%
Add 134.5%
184,998
106,108

SPDR(R) S&P(R) Biotech ETF Total Holding History ($B)

To

SPDR(R) S&P(R) Biotech ETF's Asset Allocation

To

SPDR(R) S&P(R) Biotech ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

SPDR(R) S&P(R) Biotech ETF's Hypothetical Growth since 2024-06-30

SPDR(R) S&P(R) Biotech ETF's Yearly Returns

Year Portfolio % % Excess Gain %

SPDR(R) S&P(R) Biotech ETF's Holdings Heat Map

Size field:

SPDR(R) S&P(R) Biotech ETF's Holdings Bubble Chart

SPDR(R) S&P(R) Biotech ETF News

  • 1

Discussions on SPDR Biotech ETF

User's Avatar
How would you rate this stock? XBI
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.